共 19 条
[1]
AchironA,KishnerI,Sarova PinhasI,etal.Intravenousimmunoglobulin treatmentfollowingthefirstdemyelinatingeventsuggestiveofmultiple sclerosis:arandomized,double blind,placebo controlledtrial. Archives of Neurology . 2004
[2]
BieberA,AsakuraK,WarringtonA,etal.Antibody mediatedremyelination relevancetomultiplesclerosis. MultScler . 2000
[3]
DadaMA,KaplanAA.PlasmapheresistreatmentinGuillain Barresyndrome potentialbenefitoverIVIginpatientswithaxonalinvolvement. Ther ApherDial . 2004
[4]
HahnAF.Intravenousimmunoglobulintreatmentinperipheralnerve disorders indications,mechanismsofactionandside effects. CurrOpin Neuro . 2000
[5]
DalakasMC.Intravenousimmuneglobulintherapyforneurologicdiseases. Annals of Internal Medicine . 1997
[6]
VanDoornPA,GarsssenMP.Treatmentofimmuneneuropathies. Curr OpinNeurol . 2002
[7]
DRUGS[P]. DOI TAKAYUKI;YAMAMOTO MASAKI;FUKUI HIDEO.EP1145714A4,2004-12-15
[8]
FazekasF,DeisenhammerF,Strausser FuchsS,etal.Randomisedplacebo controlledtrialofmonthlyintravenousimmunoglobulintherapyinrelapsing remittingmultiplesclerosis. The Lancet . 1997
[9]
Nobile OrazioE,CappellariA,MeucciN,etal.Multifocalmotorneuropathy:clinicalandimmunologicalfeaturesandresponsetoIVIginrelationtothe presenceanddegreeofmotorconductionblock. Journal of Neurology Neurosurgery and Psychiatry . 2002
[10]
PavelkoKD,vanEngelenBG,RodriguezM.AccelerationintherateofCNS remyelinationinlysolecithin induceddemyelination. The Journal of Neuroscience . 1998